|
AU6012696A
(en)
|
1995-06-14 |
1997-01-15 |
Aberdeen University |
Prognostic and therapeutic system for cancer
|
|
US6300060B1
(en)
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
|
USRE38490E1
(en)
|
1995-11-16 |
2004-04-06 |
Baylor College Of Medicine |
Method for identifying metastatic sequences
|
|
US5712097A
(en)
|
1996-01-19 |
1998-01-27 |
The Johns Hopkins University School Of Medicine |
Tumor suppressor gene, DPC4
|
|
ATE305140T1
(de)
|
1996-07-15 |
2005-10-15 |
Mayo Foundation |
Verfahren zur detektion der hk2 polypeptide
|
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
|
US6190857B1
(en)
|
1997-03-24 |
2001-02-20 |
Urocor, Inc. |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes
|
|
WO1999004238A2
(en)
|
1997-07-15 |
1999-01-28 |
Mitotix, Inc. |
Reagents and methods for diagnosis and prognosis of proliferative disorders
|
|
US20020165143A1
(en)
|
1997-12-03 |
2002-11-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
FI980488A7
(fi)
|
1998-03-04 |
1999-09-05 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
|
AU4158799A
(en)
|
1998-06-06 |
1999-12-30 |
Genostic Pharma Limited |
Probes used for genetic filing
|
|
GB2339200B
(en)
|
1998-06-06 |
2001-09-12 |
Genostic Pharma Ltd |
Genostics
|
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
WO2000040749A2
(en)
|
1999-01-06 |
2000-07-13 |
Genenews Inc. |
Method for the detection of gene transcripts in blood and uses thereof
|
|
CA2360073C
(en)
*
|
1999-01-28 |
2011-01-18 |
Gen-Probe Incorporated |
Probes and primers for detecting prostate specific antigen (psa) in a biological sample
|
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
|
FI990382A0
(fi)
|
1999-02-23 |
1999-02-23 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
|
EP1961818A3
(en)
|
1999-04-09 |
2008-09-10 |
Chugai Seiyaku Kabushiki Kaisha |
Novel fetal genes
|
|
US6692916B2
(en)
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
|
US6960439B2
(en)
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
|
GB9926805D0
(en)
|
1999-11-13 |
2000-01-12 |
Zeneca Ltd |
Diagnostic methods
|
|
NZ520095A
(en)
*
|
2000-01-13 |
2004-05-28 |
Genentech Inc |
Novel Stra6 polypeptides, nucleic acids, antibodies, compositions and methods of treatments for inhibiting tumor cell growth
|
|
US6448086B1
(en)
|
2000-01-18 |
2002-09-10 |
Diagnostic Systems Laboratories, Inc. |
Insulin-like growth factor system and cancer
|
|
US6566130B1
(en)
|
2000-01-28 |
2003-05-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Androgen-regulated gene expressed in prostate tissue
|
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
|
AU2002214576A1
(en)
|
2000-10-13 |
2002-04-22 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genes related to development of refractory prostate cancer
|
|
AU2002216009A1
(en)
|
2000-11-03 |
2002-05-15 |
Michael Giesing |
Clinical and functional validation of targets from disseminated cancer cells
|
|
WO2002074156A2
(en)
|
2001-02-02 |
2002-09-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
US20060088823A1
(en)
|
2001-03-29 |
2006-04-27 |
Brian Haab |
Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
|
|
US20040203012A1
(en)
|
2001-05-25 |
2004-10-14 |
Eleftherios Diamandis |
Method of detecting and monitoring prostate and ovarian cancers
|
|
US20030138793A1
(en)
|
2001-06-10 |
2003-07-24 |
Irm Llc, A Delaware Limited Liability Company |
Molecular signatures of commonly fatal carcinomas
|
|
WO2003009814A2
(en)
|
2001-07-25 |
2003-02-06 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
|
US20100297657A1
(en)
|
2001-08-02 |
2010-11-25 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US7700293B2
(en)
|
2001-08-02 |
2010-04-20 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
JP5236856B2
(ja)
|
2001-11-09 |
2013-07-17 |
ライフ テクノロジーズ コーポレーション |
遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定
|
|
AU2002357747A1
(en)
|
2001-12-10 |
2003-06-23 |
Millennium Pharmaceuticals Inc. |
Novel genes encoding colon cancer antigens
|
|
US6949342B2
(en)
|
2001-12-21 |
2005-09-27 |
Whitehead Institute For Biomedical Research |
Prostate cancer diagnosis and outcome prediction by expression analysis
|
|
US20030215835A1
(en)
|
2002-01-15 |
2003-11-20 |
Zairen Sun |
Differentially-regulated prostate cancer genes
|
|
JP2005519606A
(ja)
*
|
2002-03-14 |
2005-07-07 |
エグゾニ・テラピューティック・ソシエテ・アノニム |
ヒトカリクレイン−２及びカリクレイン−３のバリアント並びにそれらの使用
|
|
AUPS187002A0
(en)
*
|
2002-04-22 |
2002-05-30 |
Queensland University Of Technology |
Condition-specific molecules and uses therefor
|
|
CA2498418A1
(en)
|
2002-09-10 |
2004-03-25 |
Guennadi V. Glinskii |
Gene segregation and biological sample classification methods
|
|
AU2003276973A1
(en)
|
2002-09-25 |
2004-04-19 |
Amersham Biosciences (Sv) Corp. |
Detection methods
|
|
WO2004053106A2
(en)
|
2002-12-05 |
2004-06-24 |
Regulome Corporation |
Profiled regulatory sites useful for gene control
|
|
WO2004070056A2
(en)
|
2003-02-07 |
2004-08-19 |
Diagnocure Inc. |
Method to detect prostate cancer in a sample
|
|
WO2004077942A2
(en)
|
2003-02-28 |
2004-09-16 |
Genpath Pharmaceuticals, Incorporated |
Inducible prostate cancer model
|
|
EP1620573A4
(en)
|
2003-04-15 |
2006-12-20 |
Avalon Pharmaceuticals |
DETERMINATION OF CANCER-ASSOCIATED GENES AND THERAPEUTIC OBJECTS USING MOLECULAR CYTOGENETIC PROCEDURES
|
|
WO2004108896A2
(en)
*
|
2003-06-03 |
2004-12-16 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
|
|
DK1641810T4
(en)
|
2003-06-24 |
2017-07-03 |
Genomic Health Inc |
Predicting the likelihood of cancer recurrence
|
|
ES2905579T3
(es)
*
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
|
|
WO2005007830A2
(en)
|
2003-07-14 |
2005-01-27 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for diagnosis, staging and prognosis of prostate cancer
|
|
JP2007507204A
(ja)
|
2003-07-29 |
2007-03-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
サイクリン依存性キナーゼモデュレーションのバイオマーカー
|
|
EP1709152A4
(en)
|
2003-12-15 |
2007-11-07 |
Univ California |
MOLECULAR SIGNATURE OF PTEN TUMOR SUPPRESSOR
|
|
WO2005068664A2
(en)
|
2004-01-09 |
2005-07-28 |
The Regents Of The University Of California |
Cell-type-specific patterns of gene expression
|
|
GB0400976D0
(en)
|
2004-01-16 |
2004-02-18 |
Univ Cambridge Tech |
Methods of diagnosis
|
|
WO2005076005A2
(en)
|
2004-01-30 |
2005-08-18 |
Medizinische Universität Wien |
A method for classifying a tumor cell sample based upon differential expression of at least two genes
|
|
JP2005211023A
(ja)
|
2004-01-30 |
2005-08-11 |
Hayashibara Biochem Lab Inc |
腎細胞癌の転移若しくは再発の可能性を予測する方法
|
|
WO2005083128A2
(en)
|
2004-02-25 |
2005-09-09 |
University Of South Florida |
Methods for predicting cancer outcome and gene signatures for use therein
|
|
US20070224596A1
(en)
|
2004-04-09 |
2007-09-27 |
Mariana Nacht |
Compositions and methods for the modifying hypoxia induced gene regulation
|
|
EP1737980A2
(en)
|
2004-04-09 |
2007-01-03 |
Fondazione IRCCS Istituto Nazionale dei Tumori |
Gene expression markers for predicting response to chemotherapy
|
|
WO2005111619A1
(en)
|
2004-04-29 |
2005-11-24 |
Marc Ramael |
Method and kit for detecting components in a sample
|
|
AU2005245815B2
(en)
|
2004-05-07 |
2011-06-09 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
|
|
WO2005117943A2
(en)
|
2004-05-27 |
2005-12-15 |
Vertex Pharmaceuticals Incorporated |
Biomarkers for monitoring inhibition of impdh pathway
|
|
EP1756309A2
(en)
|
2004-06-03 |
2007-02-28 |
Bayer HealthCare AG |
Methods for predicting and monitoring response to cancer therapy
|
|
WO2006005043A2
(en)
|
2004-06-30 |
2006-01-12 |
Cemines, Inc. |
Compositions and methods for detecting protein interactions with target dna sequences
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
CA2576624A1
(en)
|
2004-08-13 |
2006-03-16 |
Millennium Pharmaceuticals, Inc. |
Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
|
US7572640B2
(en)
|
2004-09-28 |
2009-08-11 |
Singulex, Inc. |
Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
|
|
CA2585571C
(en)
*
|
2004-11-05 |
2020-01-21 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
|
EP1824995A2
(en)
|
2004-11-24 |
2007-08-29 |
St. George's Enterprises Limited |
Diagnosis of prostate cancer
|
|
AU2005316291A1
(en)
|
2004-12-17 |
2006-06-22 |
Veridex Llc |
Methods for assessing patients with acute myeloid leukemia
|
|
US7943306B2
(en)
|
2005-01-12 |
2011-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene expression signature for prediction of human cancer progression
|
|
US8168602B2
(en)
|
2005-02-17 |
2012-05-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
|
|
US7666595B2
(en)
*
|
2005-02-25 |
2010-02-23 |
The Brigham And Women's Hospital, Inc. |
Biomarkers for predicting prostate cancer progression
|
|
WO2006110264A2
(en)
*
|
2005-03-16 |
2006-10-19 |
Sidney Kimmel Cancer Center |
Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
|
|
WO2006105642A1
(en)
|
2005-04-05 |
2006-10-12 |
British Columbia Cancer Agency |
Biomarkers for the detection of lung cancer and uses thereof
|
|
US20090203639A1
(en)
|
2005-04-15 |
2009-08-13 |
Oncomethylome Sciences, Inc. |
Methylation Markers for Diagnoses and Treatment of Cancers
|
|
CA2608359A1
(en)
|
2005-05-13 |
2006-11-23 |
Duke University |
Gene expression signatures for oncogenic pathway deregulation
|
|
US20080275652A1
(en)
|
2005-05-13 |
2008-11-06 |
Universite Libre De Bruxelles |
Gene-based algorithmic cancer prognosis
|
|
US20060292610A1
(en)
|
2005-06-06 |
2006-12-28 |
Regents Of The University Of Michigan |
Prognostic meta signatures and uses thereof
|
|
ES2624863T3
(es)
|
2005-06-08 |
2017-07-17 |
Millennium Pharmaceuticals, Inc. |
Métodos para identificación, evaluación, y tratamiento de pacientes con terapia de cáncer
|
|
WO2006138275A2
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US7718369B2
(en)
*
|
2005-09-12 |
2010-05-18 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
EP2186912A3
(en)
|
2005-11-08 |
2011-01-19 |
Euclid Diagnostics LLC |
Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
|
|
JP5984324B2
(ja)
|
2005-12-01 |
2016-09-06 |
メディカル プログノシス インスティテュート エー／エス |
治療反応のバイオマーカーを同定するための方法および装置、ならびに治療効果を推定するためのその使用
|
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
CA2630597A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Effects of inhibitors of fgfr3 on gene transcription
|
|
US20090215054A1
(en)
|
2005-12-13 |
2009-08-27 |
Carter Scott L |
Prognosis indicators for solid human tumors
|
|
WO2007075672A2
(en)
|
2005-12-23 |
2007-07-05 |
Lankenau Institute For Medical Research |
Prognostic cancer markers
|
|
NZ593224A
(en)
|
2006-01-11 |
2012-10-26 |
Genomic Health Inc |
Gene expression markers (fap) for colorectal cancer prognosis
|
|
ES2300176B1
(es)
*
|
2006-02-15 |
2009-05-01 |
Consejo Superior Investig. Cientificas |
Metodo para el diagnostico molecular de cancer de prostata, kit para implementar el metodo.
|
|
US20070218512A1
(en)
|
2006-02-28 |
2007-09-20 |
Alex Strongin |
Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
|
|
US7914988B1
(en)
|
2006-03-31 |
2011-03-29 |
Illumina, Inc. |
Gene expression profiles to predict relapse of prostate cancer
|
|
US20090098538A1
(en)
|
2006-03-31 |
2009-04-16 |
Glinsky Gennadi V |
Prognostic and diagnostic method for disease therapy
|
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
|
WO2007140352A2
(en)
|
2006-05-26 |
2007-12-06 |
Invitrogen Corporation |
Plasma membrane and secreted cancer biomarkers
|
|
EP2029020A4
(en)
|
2006-06-22 |
2010-04-21 |
Wisconsin Alumni Res Found |
USE OF STROMA COLLAGEN IN THE DIAGNOSIS AND CHARACTERIZATION OF BREAST CANCER
|
|
WO2008036717A2
(en)
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
|
WO2008046510A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Healthcare Ag |
Fn1 as a biomarker, therapeutic and diagnostic target
|
|
WO2008048570A2
(en)
|
2006-10-16 |
2008-04-24 |
The Ohio State University Research Foundation |
Piwil2-related biomarkers and cell lines useful therewith
|
|
WO2008067065A2
(en)
*
|
2006-10-19 |
2008-06-05 |
Shiv Srivastava |
Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
|
|
US8338109B2
(en)
|
2006-11-02 |
2012-12-25 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
|
JP2010509598A
(ja)
|
2006-11-13 |
2010-03-25 |
ライフ テクノロジーズ コーポレーション |
前立腺癌バイオマーカーを検出するための方法およびキット
|
|
US20080131887A1
(en)
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
|
US20100015620A1
(en)
|
2006-12-06 |
2010-01-21 |
Strovel Jeffrey W |
Cancer-linked genes as biomarkers to monitor response to impdh inhibitors
|
|
AT504702A1
(de)
|
2006-12-22 |
2008-07-15 |
Arc Austrian Res Centers Gmbh |
Set von tumormarkern
|
|
WO2008086342A2
(en)
|
2007-01-09 |
2008-07-17 |
Bristol-Myers Squibb Company |
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells
|
|
US20090047694A1
(en)
|
2007-08-17 |
2009-02-19 |
Shuber Anthony P |
Clinical Intervention Directed Diagnostic Methods
|
|
US20090258795A1
(en)
|
2007-03-15 |
2009-10-15 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
WO2008122447A2
(en)
|
2007-04-10 |
2008-10-16 |
Epigenomics Ag |
Dna methylation assay for the diagnosis or prognosis of medical conditions
|
|
WO2008141275A1
(en)
|
2007-05-11 |
2008-11-20 |
The Johns Hopkins University |
Biomarkers for melanoma
|
|
JP2010529834A
(ja)
|
2007-05-21 |
2010-09-02 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
癌遺伝子の発見のための組成物および方法
|
|
WO2009021338A1
(en)
|
2007-08-15 |
2009-02-19 |
UNIVERSITé DE SHERBROOKE |
Alternative splicing gene variants in cancer detection
|
|
CA2695814A1
(en)
|
2007-09-07 |
2009-04-23 |
Universite Libre De Bruxelles |
Methods and tools for prognosis of cancer in her2+ patients
|
|
WO2009051734A1
(en)
|
2007-10-17 |
2009-04-23 |
The General Hospital Corporation |
Microchip-based devices for capturing circulating tumor cells and methods of their use
|
|
GB0721605D0
(en)
|
2007-11-02 |
2007-12-12 |
Cancer Rec Tech Ltd |
Prostrate cancer susceptibility screening
|
|
US20090123439A1
(en)
|
2007-11-09 |
2009-05-14 |
The Jackson Laboratory |
Diagnostic and prognosis methods for cancer stem cells
|
|
WO2009070767A2
(en)
|
2007-11-28 |
2009-06-04 |
Whitehead Institute For Biomedical Research |
Systemic instigation systems to study tumor growth or metastasis
|
|
EP2065474A1
(en)
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic response to endocrine treatment
|
|
WO2009068423A2
(en)
|
2007-11-30 |
2009-06-04 |
Siemens Healthcare Diagnostics Gmbh |
Method for predicting therapy responsiveness in basal like tumors
|
|
WO2009089521A2
(en)
|
2008-01-10 |
2009-07-16 |
Nuvera Biosciences, Inc. |
Predictors for evaluating response to cancer therapy
|
|
WO2009105154A2
(en)
|
2008-02-19 |
2009-08-27 |
The Jackson Laboratory |
Diagnostic and prognostic methods for cancer
|
|
WO2009105640A1
(en)
|
2008-02-22 |
2009-08-27 |
Virginia Commonwealth University |
Signatures associated with rejection or recurrence of cancer
|
|
US8067178B2
(en)
|
2008-03-14 |
2011-11-29 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
EP2274699A4
(en)
|
2008-03-26 |
2011-04-27 |
Theranos Inc |
METHOD AND SYSTEMS FOR EVALUATING CLINICAL RESULTS
|
|
EP2105511A1
(en)
|
2008-03-28 |
2009-09-30 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
|
|
WO2009124251A1
(en)
|
2008-04-03 |
2009-10-08 |
Sloan-Kettering Institute For Cancer Research |
Gene signatures for the prognosis of cancer
|
|
WO2009126122A1
(en)
|
2008-04-10 |
2009-10-15 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc |
Prostate cancer-specific alterations in erg gene expression and detection and treatment methods based on those alterations
|
|
US20110124003A1
(en)
|
2008-04-25 |
2011-05-26 |
Integrated Bioscience Solutions, Llc |
Cytological Methods for Detecting Cancer
|
|
US8093000B2
(en)
|
2008-05-09 |
2012-01-10 |
The Regents Of The University Of California |
Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
|
|
US20110065605A1
(en)
|
2008-05-14 |
2011-03-17 |
Eth Zurich |
Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
|
|
WO2009139915A2
(en)
|
2008-05-15 |
2009-11-19 |
The University Of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
|
WO2009140741A1
(en)
|
2008-05-23 |
2009-11-26 |
The University Of Queensland |
Agents and methods for diagnosing the presence or risk of prostate cancer
|
|
GB0809689D0
(en)
|
2008-05-28 |
2008-07-02 |
Cancer Res Inst Royal |
Markers for prostate cancee
|
|
EP2806054A1
(en)
|
2008-05-28 |
2014-11-26 |
Genomedx Biosciences Inc. |
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
|
US20090298082A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Klee George G |
Biomarker panels for predicting prostate cancer outcomes
|
|
WO2009149166A2
(en)
|
2008-06-03 |
2009-12-10 |
Children's Hospital Medical Center |
Methods and compositions for the diagnosis and treatment of proliferative disorders
|
|
RU2011101378A
(ru)
|
2008-06-16 |
2012-07-27 |
Сайвидон Дайагностикс Гмбх (De) |
Алгоритмы предсказания исхода у пациентов с узловой формой рака молочной железы после химиотерапии
|
|
EP2315858A2
(en)
|
2008-07-08 |
2011-05-04 |
Source Precision Medicine, Inc. |
Gene expression profiling for predicting the survivability of prostate cancer subjects
|
|
AU2009270851A1
(en)
|
2008-07-16 |
2010-01-21 |
Dana-Farber Cancer Institute, Inc. |
Signatures and PCDETERMINANTS associated with prostate cancer and methods of use thereof
|
|
CA2731459A1
(en)
|
2008-07-21 |
2010-01-28 |
The Translational Genomics Research Institute |
Methods for diagnosis and prognosis of skin cancer
|
|
EP2324111B1
(en)
|
2008-09-10 |
2013-07-03 |
Life & Brain GmbH |
Peripheral zone tumor cells, methods for their preparation and use
|
|
ES2469802T3
(es)
|
2008-10-20 |
2014-06-20 |
Valipharma |
Métodos y usos que implican aberraciones genéticas de NAV 3 y expresión aberrante de múltiples genes
|
|
CN102203131A
(zh)
|
2008-10-22 |
2011-09-28 |
霍夫曼-拉罗奇有限公司 |
前列腺干细胞及其用途
|
|
BRPI0919882A8
(pt)
|
2008-10-30 |
2017-09-19 |
Caris Life Sciences Luxembourg Holdings |
Métodos para avaliar padrões de rna
|
|
US20110230361A1
(en)
*
|
2008-11-14 |
2011-09-22 |
Emory University |
Prostate cancer biomarkers to predict recurrence and metastatic potential
|
|
WO2010056351A2
(en)
|
2008-11-14 |
2010-05-20 |
Stc.Unm |
Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia
|
|
GB0821787D0
(en)
|
2008-12-01 |
2009-01-07 |
Univ Ulster |
A genomic-based method of stratifying breast cancer patients
|
|
CN102308212A
(zh)
|
2008-12-04 |
2012-01-04 |
加利福尼亚大学董事会 |
用于确定前列腺癌诊断和预后的材料和方法
|
|
AU2010203825A1
(en)
|
2009-01-06 |
2011-07-21 |
Genomic Health, Inc. |
Gene expression profiling for the identification, monitoring, and treatment of prostate cancer
|
|
ES2991436T3
(es)
|
2009-01-07 |
2024-12-03 |
Myriad Genetics Inc |
Biomarcadores de cáncer
|
|
CA2749601C
(en)
|
2009-01-14 |
2020-07-21 |
Stephen M. Hewitt |
Ratio based biomarkers and methods of use thereof
|
|
BRPI1007048A2
(pt)
|
2009-01-15 |
2016-02-10 |
Lab Corp America Holdings |
método e kit para correlacionar os níveis relativos da quantidade de pelo menos um de her-2 ou homodímeros de her-2 em uma amostra biológica de um indivíduo, e , método para prognosticar se um indivíduo com câncer e que é tratado com um agente que atua em her-2 é provável ter um evento significante.
|
|
EP2233590A1
(en)
|
2009-01-28 |
2010-09-29 |
AIT Austrian Institute of Technology GmbH |
Methylation assay
|
|
EP2399130A4
(en)
|
2009-02-20 |
2012-06-06 |
Wayne John Cancer Inst |
ASSAY OF B7-H3 ANTIBODY-COUPLED BEADS FOR THE ISOLATION AND DETECTION OF CIRCULATING TUMOR CELLS IN THE BODILY FLUIDS OF MELANOMA AND BREAST CANCER PATIENTS
|
|
WO2010099577A1
(en)
|
2009-03-04 |
2010-09-10 |
The University Of Queensland |
Cancer biomarkers and uses therefor
|
|
US8341318B2
(en)
|
2009-03-16 |
2012-12-25 |
Apple Inc. |
Techniques for facilitating communication between an accessory and a mobile computing device using application specific protocols
|
|
US8765383B2
(en)
|
2009-04-07 |
2014-07-01 |
Genomic Health, Inc. |
Methods of predicting cancer risk using gene expression in premalignant tissue
|
|
AU2010237568A1
(en)
|
2009-04-16 |
2011-11-17 |
National Research Council Of Canada |
Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer
|
|
EP2241634A1
(en)
|
2009-04-16 |
2010-10-20 |
Université Libre de Bruxelles |
Diagnostic method and tools to predict the effiacy of targeted agents against IGF-1 pathway activation in cancer
|
|
WO2010127399A1
(en)
|
2009-05-06 |
2010-11-11 |
Walter And Eliza Hall Institute Of Medical Research |
Gene expression profiles and uses thereof
|
|
WO2010129965A1
(en)
|
2009-05-08 |
2010-11-11 |
The Regents Of The University Of California |
Cancer specific mitotic network
|
|
US20100303795A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Soerensen Karina Dalsgaard |
Marker of prostate cancer
|
|
US10095829B2
(en)
|
2009-07-08 |
2018-10-09 |
Worldwide Innovative Network |
Computer implemented methods of treating lung cancer
|
|
WO2011039734A2
(en)
|
2009-10-02 |
2011-04-07 |
Enzo Medico |
Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
|
|
JP5964752B2
(ja)
|
2009-11-23 |
2016-08-03 |
ジェノミック ヘルス， インコーポレイテッド |
癌の臨床転帰を予測する方法
|
|
MX375138B
(es)
|
2010-01-11 |
2025-03-06 |
Genomic Health Inc |
Método para usar expresión génica para determinar la probabilidad de un desenlace clínico de cáncer renal.
|
|
EP2913405B1
(en)
|
2010-07-27 |
2016-11-09 |
Genomic Health, Inc. |
Method for using gene expression to determine prognosis of prostate cancer
|
|
WO2014108896A1
(en)
|
2013-01-08 |
2014-07-17 |
Marpe Technologies Ltd. |
Device and method for body moles mapping and tracking
|